Biotech venture firm plans major London expansion |
| Flagship Pioneering, the life sciences venture firm behind Moderna, which helped pioneer Covid-19 vaccines using mRNA technology, has announced its first full-scale site outside the US. The company said it is to commit £100m ($132m) over the next few years to build out a London-based lab that “will conceive, test, fund and build” AI-focused biotech firms in human health, environmental science and agriculture, with the goal of establishing eight to 10 new UK-based biotechs. Flagship CEO Noubar Afeyan said he was attracted to London because of its world-class biomedical research infrastructure, deep AI expertise and strong clinical capabilities. “Our goal is to establish an ecosystem of companies,” Afeyan explained. Chris McDonald, UK minister for science, innovation and investment said: “The UK is a natural home for AI and life sciences companies, and we want to see more new businesses across these sectors turning cutting-edge research and technology into new jobs and economic growth.” |
|